SILO Pharma Inc (NASDAQ: SILO) is 102.25% higher on its value in year-to-date trading and has touched a low of $0.77 and a high of $4.50 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SILO stock was last observed hovering at around $1.72 in the last trading session, with the day’s gains setting it 0.08%.
Currently trading at $1.80, the stock is 65.47% and 70.81% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.78 million and changing 4.65% at the moment leaves the stock 29.85% off its SMA200. SILO registered 21.21% gain for a year compared to 6-month loss of 68.22%. The firm has a 50-day simple moving average (SMA 50) of $1.0404 and a 200-day simple moving average (SMA200) of $1.38681.
The stock witnessed a 89.55% gain in the last 1 month and extending the period to 3 months gives it a 74.76%, and is 81.15% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 40.34% over the week and 17.27% over the month.
SILO Pharma Inc (SILO) has around 3 employees, a market worth around $8.07M and $0.07M in sales. Profit margin for the company is -5247.34%. Distance from 52-week low is 133.77% and -60.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-55.78%).
.
SILO Pharma Inc (SILO) Top Institutional Holders
9.0 institutions hold shares in SILO Pharma Inc (SILO), with institutional investors hold 2.56% of the company’s shares. The shares outstanding are 4.48M, and float is at 4.29M with Short Float at 4.96%. Institutions hold 2.46% of the Float.
SILO Pharma Inc (SILO) Insider Activity
The most recent transaction is an insider purchase by Weisblum Eric, the company’s CEO and President. SEC filings show that Weisblum Eric bought 2,500 shares of the company’s common stock on Dec 13 ’24 at a price of $0.84 per share for a total of $2097.0. Following the purchase, the insider now owns 0.19 million shares.
SILO Pharma Inc disclosed in a document filed with the SEC on Nov 20 ’24 that Weisblum Eric (CEO and President) bought a total of 2,500 shares of the company’s common stock. The trade occurred on Nov 20 ’24 and was made at $0.95 per share for $2375.0. Following the transaction, the insider now directly holds 0.18 million shares of the SILO stock.
Still, SEC filings show that on Nov 22 ’24, Weisblum Eric (CEO and President) acquired 2,500 shares at an average price of $0.90 for $2250.0. The insider now directly holds 185,432 shares of SILO Pharma Inc (SILO).
